Robertson Stephens Wealth Management’s GSK GSK Stock Holding History

Robertson Stephens Wealth Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.64M	Sell	163,317 -849	-0.5%	-$44.9K	0.21%	87
2026 Q1	$9.14M	Buy	164,166 +2,504	+2%	+$136K	0.26%	74
2025 Q4	$8M	Buy	+161,662	New	+$7.54M	0.21%	94
2022 Q3	–	Sell	-4,600	Closed	-$252K	–	374
2022 Q2	$252K	Buy	+4,600	New	+$254K	0.02%	317
2020 Q3	–	Sell	-8,629	Closed	-$449K	–	240
2020 Q2	$449K	Sell	8,629 -8,441	-49%	-$433K	0.13%	118
2020 Q1	$826K	Buy	+17,070	New	+$911K	0.28%	76

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Robertson Stephens Wealth Management's GSK Position: Q2 2026 in Review

Robertson Stephens Wealth Management reduced its GSK (GSK) stake by 0.52% in Q2 2026, selling an estimated $44.9K and leaving 163,317 shares worth $8.64M. The position accounts for 0.21% of the portfolio, ranked #87.

Robertson Stephens Wealth Management first reported a position in GSK in Q1 2020 and has held it in 6 quarters since. The position peaked at $9.14M in Q1 2026. 1,038 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Robertson Stephens Wealth Management held 163,317 shares of GSK worth $8.64M as of Q2 2026.
Robertson Stephens Wealth Management sold 849 GSK shares in Q2 2026, an estimated $44.9K.
GSK made up 0.21% of Robertson Stephens Wealth Management's portfolio in Q2 2026, its #87 holding.
Robertson Stephens Wealth Management first reported a position in GSK in Q1 2020 and has held it in 6 quarters since.
Robertson Stephens Wealth Management's GSK position peaked at $9.14M in Q1 2026.
1,038 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Robertson Stephens Wealth Management's 13F filing for Q2 2026, filed 29 Jul 2026.